Close Menu

NEW YORK (GenomeWeb) – Invitae announced today that it has acquired privately owned data company AltaVoice. Under the terms of the deal, Invitae purchased all of AltaVoice's stock in exchange for $5 million in Invitae common stock and up to an additional $10 million in Invitae common stock if certain future milestones are met.

The acquisition will add to Invitae's Genome Network, the company said, which connects patients, clinicians, advocacy organizations, researchers, and pharma companies to advance the understanding of hereditary disease and its possible treatments.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.

Michael Caputo, the top Department of Health and Human Service spokesperson, is taking a leave of absence, CNN says.

CNBC reports that the CDC Director says a SARS-CoV-2 vaccine isn't likely to be generally available until the third quarter of 2021, timing President Donald Trump disputes.

In Nature this week: MassIVE.quant resource houses mass spectrometry-based proteomic data, influence of Viking genetics on European populations, and more.